IIM
TARA icon

INTECH Investment Management’s Protara Therapeutics TARA Stock Holding History

INTECH Investment Management’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.8K Sell
13,562
-227
-2% -$1.08K ﹤0.01% 2046
2026
Q1 		$71.8K Sell
13,789
-32
-0.2% -$189 ﹤0.01% 1958
2025
Q4 		$73.7K Sell
13,821
-2,079
-13% -$11.6K ﹤0.01% 2215
2025
Q3 		$69.2K Sell
15,900
-211
-1% -$683 ﹤0.01% 2336
2025
Q2 		$48.8K Buy
+16,111
New +$55.6K ﹤0.01% 2420

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

INTECH Investment Management's TARA Position: Q2 2026 in Review

INTECH Investment Management reduced its Protara Therapeutics (TARA) stake by 1.6% in Q2 2026, selling an estimated $1.08K and leaving 13,562 shares worth $51.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2046.

INTECH Investment Management first reported a position in TARA in Q2 2025 and has held it in 5 quarters since. The position peaked at $73.7K in Q4 2025. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • INTECH Investment Management held 13,562 shares of Protara Therapeutics worth $51.8K as of Q2 2026.
  • INTECH Investment Management sold 227 Protara Therapeutics shares in Q2 2026, an estimated $1.08K.
  • Protara Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #2046 holding.
  • INTECH Investment Management first reported a position in Protara Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • INTECH Investment Management's Protara Therapeutics position peaked at $73.7K in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.